Sanofi flat as EPS decline and 52W low weigh on value score
Sanofi shares edged up 0.04% to $48.39 on Monday, holding near the bottom of a 52-week range that stretches from $69.75 to $90.07. The stock has shed roughly 30% from its high, with the P/E compressing to 14.77 on trailing earnings of $5.78 per share. Revenue grew 13.4% year over year, but EPS fell 55.6%, dragging net margin to 10.9%. The Alpha Score of 45.8 reflects a split profile: value scores 59.8 and momentum 50.6, while quality sits at 42.1. The EPS decline, driven by a high base effect from prior-year one-time gains, has overshadowed top-line growth. The next catalyst is the Q4 earnings report, due in early February, where investors will look for margin stabilization and an update on the pipeline.